EMERYVILLE, Kalifornien - NovaBay Pharmaceuticals, Inc. (NYSE American: NBY) hat den Verkauf seiner Avenova-Marke an PRN Physician Recommended Nutriceuticals, LLC für 9,5 Millionen US-Dollar in bar be ...
Some results have been hidden because they may be inaccessible to you